MCM
IRWD icon

MV Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

MV Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-712
Closed -$8K – 682
2021
Q1 		$8K Hold
712
– – ﹤0.01% 254
2020
Q4 		$8K Hold
712
– – ﹤0.01% 251
2020
Q3 		$6K Hold
712
– – ﹤0.01% 237
2020
Q2 		$7K Hold
712
– – ﹤0.01% 239
2020
Q1 		$7K Hold
712
– – ﹤0.01% 233
2019
Q4 		$9K Buy
+712
New +$7.85K ﹤0.01% 254

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

MV Capital Management's IRWD Position: Q2 2021 in Review

MV Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 712 shares — an estimated $8K sold.

MV Capital Management first reported a position in IRWD in Q4 2019 and held it in 6 quarters. The position peaked at $9K in Q4 2019. 208 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

  • MV Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • MV Capital Management sold 712 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $8K.
  • MV Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 6 quarters.
  • MV Capital Management's Ironwood Pharmaceuticals position peaked at $9K in Q4 2019.
  • 208 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on MV Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.